Sponsor

Emerald Clinical Inc.

Clinical research sponsor

Published trials7

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

7 shown

Dapagliflozin Treatment in Type 2 DiabetesNCT04620590 · lead sponsor · 2021-04-20

COMPLETED

Protocol for a Multicentre Survey of Patients With Treatment Resistant HypertensionNCT03078244 · lead sponsor · 2016-11-01

COMPLETED

Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the LungNCT01759303 · lead sponsor · 2013-04-01

TERMINATED

Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without DiabetesNCT07098663 · collaborator · 2025-08-12

RECRUITING

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseNCT04492722 · collaborator · 2020-10-01

TERMINATED

Global Kidney Patient Trials NetworkNCT04389827 · collaborator · 2020-05-05

COMPLETED

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast CancerNCT03403712 · collaborator · 2018-03-16

COMPLETED

Sponsor roles

collaborator4

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.